Lannett Co Inc (LCI) : Lannett Co Inc (LCI) had a healthy money flow of $1.34 million into the stock during the Tuesdays trading session. The value of bullish trades on upticks was $6.41 million, whereas, investors only sold shares worth $5.06 million on downticks. The stock closed the day with an up-down ratio of 1.27.The money flow in the block trades to the tune of $1.72 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $1.72 million worth of transactions were on upticks. Lannett Co Inc (LCI) stock slid $0.04 intraday and traded at 27.68, a change of -0.14% over previous days close. However, for the week, the company shares are 12.57% compared to previous weeks close.
The company Insiders own 15.1% of Lannett Co Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -83.94% . Institutional Investors own 75.84% of Lannett Co Inc shares. During last six month period, the net percent change held by insiders has seen a change of -2.58%. In an insider trading activity, Dedhiya Mahendra, officer (Chief Scientific Affairs) of Lannett Co Inc, executed a transaction worth $24,840 on February 5, 2016. A total of 1,000 shares were purchased at an average price of $24.84. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Shares of Lannett Company, Inc. rose by 11.51% in the last five trading days and 18.53% for the last 4 weeks. Lannett Company, Inc. is up 57.02% in the last 3-month period. Year-to-Date the stock performance stands at -31.43%.
Lannett Co Inc (NYSE:LCI): On Tuesdays trading session , Opening price of the stock was $27.75 with an intraday high of $27.81. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $26.82. However, the stock managed to close at $27.51, a loss of 0.76% for the day. On the previous day, the stock had closed at $27.72. The total traded volume of the day was 1,054,001 shares.
Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Companys products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.